Intervention not reported
PUFA(2 trials; 95 participants) · people with non‐alcohol‐related fatty liver disease (NAFLD)
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Intervention not reported
Vitamin E(1 trial; 167 participants) · people with non‐alcohol‐related fatty liver disease (NAFLD)
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Intervention not reported
Prebiotics/Probiotics/Synbiotics(6 trials; 296 participants) · people with non‐alcohol‐related fatty liver disease (NAFLD)
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Intervention not reported
Prebiotics/Probiotics/Synbiotics(5 trials; 289 participants) · people with non‐alcohol‐related fatty liver disease (NAFLD)
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Intervention not reported
PUFA(9 trials; 750 participants) · people with non‐alcohol‐related fatty liver disease (NAFLD)
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Intervention not reported
Vitamin E(4 trials; 379 participants) · people with non‐alcohol‐related fatty liver disease (NAFLD)
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Intervention not reported
Other antioxidants(3 trials; 191 participants) · people with non‐alcohol‐related fatty liver disease (NAFLD)
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Intervention not reported
Vitamin D(4 trials; 241 participants) · people with non‐alcohol‐related fatty liver disease (NAFLD)
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Intervention not reported
Amino acids(2 trials; 158 participants) · people with non‐alcohol‐related fatty liver disease (NAFLD)
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Intervention not reported
AFP (cut‐off 20 ng/mL) · adults with chronic liver disease
1 finding from 1 review
Intervention not reported
AFP (cut‐off 200 ng/mL) · adults with chronic liver disease
1 finding from 1 review
Intervention not reported
US · adults with chronic liver disease
1 finding from 1 review
Intervention not reported
Combination of AFP (cut‐off 20 ng/mL) and US · adults with chronic liver disease
1 finding from 1 review
Intervention not reported
US · adults with chronic liver disease
1 finding from 1 review
Intervention not reported
Combination of AFP (cut‐off 20 ng/mL) and US · adults with chronic liver disease
1 finding from 1 review
Intervention not reported
CT · adults with chronic liver disease
1 finding from 1 review
Intervention not reported
CT · adults with chronic liver disease
1 finding from 1 review
All‐cause mortality · participants with cirrhosis and with previous oesophagogastric variceal bleeding
It is very uncertain whether portosystemic shunts changes all‐cause mortality compared with endoscopic intervention with or without medical treatment (very low certainty).
1 finding from 1 review
Mortality due to rebleeding · participants with cirrhosis and with previous oesophagogastric variceal bleeding
It is very uncertain whether total shunt changes mortality due to rebleeding compared with endoscopic intervention (very low certainty).
1 finding from 1 review
Acute hepatic encephalopathy · participants with cirrhosis and with previous oesophagogastric variceal bleeding
It is very uncertain whether total shunt changes acute hepatic encephalopathy compared with endoscopic intervention (very low certainty).
1 finding from 1 review